TY - JOUR
T1 - Predictive value of SAR based quality indicators for head and neck hyperthermia treatment quality
AU - Bellizzi, Gennaro G.
AU - Drizdal, Tomas
AU - van Rhoon, Gerard C.
AU - Crocco, Lorenzo
AU - Isernia, Tommaso
AU - Paulides, Margarethus M.
PY - 2019/1/1
Y1 - 2019/1/1
N2 -
Purpose: Hyperthermia treatment quality determines treatment effectiveness as shown by the clinically derived thermal-dose effect relations. SAR based optimization factors are used as possible surrogate for temperature, since they are not affected by thermal tissue properties uncertainty and variations. Previously, target coverage (TC) at the 25% and 50% iso-SAR level was shown predictive for treatment outcome in superficial hyperthermia and the target-to-hot-spot-quotient (THQ) was shown to highly correlate with predictive temperature in deep pelvic hyperthermia. Here, we investigate the correlation with temperature for THQ and TC using an ‘intermediate’ scenario: semi-deep hyperthermia in the head & neck region using the HYPERcollar3D. Methods: Fifteen patient-specific models and two different planning approaches were used, including random perturbations to circumvent optimization bias. The predicted SAR indicators were compared to predicted target temperature distribution indicators T50 and T90, i.e., the median and 90th percentile temperature respectively. Results: The intra-patient analysis identified THQ, TC25 and TC50 as good temperature surrogates: with a mean correlation coefficient R
2
T50
= 0.72 and R
2
T90
=0.66. The inter-patient analysis identified the highest correlation with TC25 (R
2
T50
= 0.76, R
2
T90
=0.54) and TC50 (R
2
T50
= 0.74, R
2
T
90
= 0.56). Conclusion: Our investigation confirmed the validity of our current strategy for deep hyperthermia in the head & neck based on a combination of THQ and TC25. TC50 was identified as the best surrogate since it enables optimization and patient inclusion decision making using one single parameter.
AB -
Purpose: Hyperthermia treatment quality determines treatment effectiveness as shown by the clinically derived thermal-dose effect relations. SAR based optimization factors are used as possible surrogate for temperature, since they are not affected by thermal tissue properties uncertainty and variations. Previously, target coverage (TC) at the 25% and 50% iso-SAR level was shown predictive for treatment outcome in superficial hyperthermia and the target-to-hot-spot-quotient (THQ) was shown to highly correlate with predictive temperature in deep pelvic hyperthermia. Here, we investigate the correlation with temperature for THQ and TC using an ‘intermediate’ scenario: semi-deep hyperthermia in the head & neck region using the HYPERcollar3D. Methods: Fifteen patient-specific models and two different planning approaches were used, including random perturbations to circumvent optimization bias. The predicted SAR indicators were compared to predicted target temperature distribution indicators T50 and T90, i.e., the median and 90th percentile temperature respectively. Results: The intra-patient analysis identified THQ, TC25 and TC50 as good temperature surrogates: with a mean correlation coefficient R
2
T50
= 0.72 and R
2
T90
=0.66. The inter-patient analysis identified the highest correlation with TC25 (R
2
T50
= 0.76, R
2
T90
=0.54) and TC50 (R
2
T50
= 0.74, R
2
T
90
= 0.56). Conclusion: Our investigation confirmed the validity of our current strategy for deep hyperthermia in the head & neck based on a combination of THQ and TC25. TC50 was identified as the best surrogate since it enables optimization and patient inclusion decision making using one single parameter.
KW - head & neck
KW - hyperthermia treatment planning
KW - SAR indicators
KW - Sim4Life
KW - Treatment quality
UR - http://www.scopus.com/inward/record.url?scp=85064490494&partnerID=8YFLogxK
U2 - 10.1080/02656736.2019.1590652
DO - 10.1080/02656736.2019.1590652
M3 - Article
C2 - 30973030
AN - SCOPUS:85064490494
SN - 0265-6736
VL - 36
SP - 456
EP - 465
JO - International Journal of Hyperthermia
JF - International Journal of Hyperthermia
IS - 1
ER -